Novo Nordisk A/S Common Stock (NVO)
EBITDA Margin
49.28%
Quarterly · Period ending:
NVO EBITDA Margin
Latest reported49.28%period ending
Latest reported49.28%period ending
NVO Quarterly EBITDA Margin (100.00% → 49.28%)
Quarterly ebitda margin
High-resolution chart · PNG
NVO ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 49.2801% | |
| 71.4779% | |
| 50.2211% | |
| 44.3795% | |
| 56.7235% | |
| 58.9676% | |
| 53.5089% | |
| 52.3832% | |
| 52.511% | |
| 56.4752% | |
| 43.2883% | |
| 55.7729% | |
| 49.1934% | |
| 51.6761% | |
| 19.7642% | |
| 52.2275% | |
| 52.5457% | |
| 49.9798% | |
| 36.0212% | |
| 48.8125% | |
| 48.8302% | |
| 53.5795% | |
| 36.3277% | |
| 48.8247% | |
| 50.2999% | |
| 51.3801% | |
| 29.355% | |
| 49.6449% | |
| 48.5318% | |
| 52.2686% | |
| 36.0487% | |
| 45.3714% | |
| 51.122% | |
| 53.3903% | |
| 34.5956% | |
| 47.9071% | |
| 51.2256% | |
| 50.8084% | |
| 39.3616% | |
| 47.7757% | |
| 48.1227% | |
| 47.6113% | |
| 21.3984% | |
| 47.1111% | |
| 48.5236% | |
| 58.75% | |
| 33.6018% | |
| 45.2964% | |
| 45.291% | |
| 45.598% | |
| 36.8882% | |
| 44.1373% | |
| 45.014% | |
| 42.8764% | |
| 30.9799% | |
| 39.6271% | |
| 40.0606% | |
| 36.2346% | |
| 33.5706% | |
| 34.8657% | |
| 34.5916% | |
| 35.0602% | |
| 38.4458% | |
| 36.8326% | |
| 37.5341% | |
| 37.2459% | |
| 25.0727% | |
| 35.7354% | |
| 36.751% | |
| 36.1978% | |
| 26.8682% | |
| 31.7624% | |
| 25.629% | |
| 30.488% | |
| 10.4511% | |
| 25.5224% | |
| 26.6007% | |
| 23.6498% | |
| 20.0597% | |
| 26.0736% | |
| 27.0546% | |
| 26.2723% | |
| 20.3854% | |
| 26.2526% | |
| 28.3482% | |
| 20.807% | |
| 22.9402% | |
| 23.5437% | |
| 26.3605% | |
| 23.1482% | |
| -136.7501% | |
| 84.3453% | |
| 84.5618% | |
| 84.0402% | |
| -187.046% | |
| 100% | |
| 100% | |
| 100% | |
| -178.6312% | |
| 100% |